Page last updated: 2024-11-05

thalidomide and Entropion

thalidomide has been researched along with Entropion in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Entropion: The turning inward (inversion) of the edge of the eyelid, with the tarsal cartilage turned inward toward the eyeball. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Periman, LM1
Sires, BS1

Other Studies

1 other study available for thalidomide and Entropion

ArticleYear
Full-thickness skin grafting of eyelids in a patient with generalized morphea taking thalidomide.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2000, Volume: 118, Issue:1

    Topics: Entropion; Eyelids; Female; Humans; Middle Aged; Scleroderma, Localized; Skin Transplantation; Thali

2000